-
A Data-Driven Simulation of the Exposure Notification Cascade for Digital Contact Tracing of SARS-CoV-2 in Zurich, Switzerland. JAMA Netw Open. 2021 04 01; 4(4):e218184.
Menges D, Aschmann HE, Moser A, Althaus CL, von Wyl V. PMID: 33929521; PMCID: PMC8087953.
View in:
PubMed Mentions:
16 Fields:
Translation:
HumansCellsPHPublic Health
-
Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults. JAMA Netw Open. 2021 04 01; 4(4):e212633.
Green AR, Aschmann H, Boyd CM, Schoenborn N. PMID: 33818621; PMCID: PMC8022217.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
[Cancer Screening - Prerequesites for a Successful and Meaningful Screening Program]. Ther Umsch. 2021; 78(2):55-60.
Aschmann HE, Puhan MA. PMID: 33615862.
View in:
PubMed Mentions: Fields:
Translation:
HumansPHPublic Health
-
Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study. BMC Cardiovasc Disord. 2020 09 17; 20(1):418.
Yebyo HG, Zappacosta S, Aschmann HE, Haile SR, Puhan MA. PMID: 32942999; PMCID: PMC7495829.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansPHPublic Health
-
Benefit-harm balance of fingolimod in patients with MS: A modelling study based on FREEDOMS. Mult Scler Relat Disord. 2020 Nov; 46:102464.
Spanu A, Aschmann HE, Kesselring J, Puhan MA. PMID: 32889373.
View in:
PubMed Mentions:
1 Fields:
Translation:
Humans
-
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments. Value Health. 2020 05; 23(5):616-624.
Aschmann HE, Boyd CM, Robbins CW, Chan WV, Mularski RA, Bennett WL, Sheehan OC, Wilson RF, Bayliss EA, Leff B, Armacost K, Glover C, Maslow K, Mintz S, Puhan MA. PMID: 32389227.
View in:
PubMed Mentions:
6 Fields:
Translation:
Humans
-
Outcome preferences of older people with multiple chronic conditions and hypertension: a cross-sectional survey using best-worst scaling. Health Qual Life Outcomes. 2019 Dec 19; 17(1):186.
Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Chan WV, Mularski RA, Wilson RF, Bennett WL, Sheehan OC, Yu T, Yebyo HG, Leff B, Tabano H, Armacost K, Glover C, Maslow K, Mintz S, Boyd CM. PMID: 31856842; PMCID: PMC6924040.
View in:
PubMed Mentions:
5 Fields:
Translation:
Humans
-
Net benefit of statins for primary prevention of cardiovascular disease in people 75 years or older: a benefit-harm balance modeling study. Ther Adv Chronic Dis. 2019; 10:2040622319877745.
Yebyo HG, Aschmann HE, Menges D, Boyd CM, Puhan MA. PMID: 31598209; PMCID: PMC6764041.
View in:
PubMed Mentions:
6
-
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 2019 08 30; 9(8):e028438.
Aschmann HE, Boyd CM, Robbins CW, Mularski RA, Chan WV, Sheehan OC, Wilson RF, Bennett WL, Bayliss EA, Yu T, Leff B, Armacost K, Glover C, Maslow K, Mintz S, Puhan MA. PMID: 31471435; PMCID: PMC6720326.
View in:
PubMed Mentions:
3 Fields:
Translation:
Humans
-
Statins for Primary Prevention of Cardiovascular Disease. Ann Intern Med. 2019 07 02; 171(1):74-76.
Yebyo HG, Aschmann HE, Puhan MA. PMID: 31261399.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansPHPublic Health
-
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Bennett WL, Aschmann HE, Puhan MA, Robbins CW, Bayliss EA, Wilson R, Mularski RA, Chan WV, Leff B, Sheehan O, Glover C, Maslow K, Armacost K, Mintz S, Boyd CM. PMID: 31059802.
View in:
PubMed Mentions:
11 Fields:
Translation:
Humans
-
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants. Am Heart J. 2019 04; 210:18-28.
Yebyo HG, Aschmann HE, Kaufmann M, Puhan MA. PMID: 30716508.
View in:
PubMed Mentions:
53 Fields:
Translation:
Humans
-
Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study. Ann Intern Med. 2019 01 01; 170(1):1-10.
Yebyo HG, Aschmann HE, Puhan MA. PMID: 30508425.
View in:
PubMed Mentions:
23 Fields:
Translation:
HumansPHPublic Health
-
Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts. BMC Cardiovasc Disord. 2018 05 18; 18(1):97.
Yebyo HG, Aschmann HE, Yu T, Puhan MA. PMID: 29776337; PMCID: PMC5960214.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansPHPublic Health
-
Kinetics of lipid bilayer permeation of a series of ionisable drugs and their correlation with human transporter-independent intestinal permeability. Eur J Pharm Sci. 2017 Jun 15; 104:150-161.
Hermann KF, Neuhaus CS, Micallef V, Wagner B, Hatibovic M, Aschmann HE, Paech F, Alvarez-Sanchez R, Krämer SD, Belli S. PMID: 28366650.
View in:
PubMed Mentions:
10 Fields:
Translation:
Humans
-
A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations. PLoS Comput Biol. 2017 02; 13(2):e1005280.
Thiel C, Cordes H, Fabbri L, Aschmann HE, Baier V, Smit I, Atkinson F, Blank LM, Kuepfer L. PMID: 28151932; PMCID: PMC5289425.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy. Antimicrob Agents Chemother. 2016 10; 60(10):6134-45.
Cordes H, Thiel C, Aschmann HE, Baier V, Blank LM, Kuepfer L. PMID: 27480867; PMCID: PMC5038291.
View in:
PubMed Mentions:
16 Fields:
Translation:
HumansCells
-
When barriers ignore the "rule-of-five". Adv Drug Deliv Rev. 2016 06 01; 101:62-74.
Krämer SD, Aschmann HE, Hatibovic M, Hermann KF, Neuhaus CS, Brunner C, Belli S. PMID: 26877103.
View in:
PubMed Mentions:
17 Fields:
Translation:
HumansAnimalsCells